Background-Na
ϩ /H ϩ exchange inhibition with HOE642 (cariporide) improves postischemic recovery of cardiac function, but the mechanisms of action remain speculative. Because Na ϩ /H ϩ exchange is activated on reperfusion, it was hypothesized that its inhibition delays realkalinization and decreases intracellular Na ϩ and, via Na Key Words: stunning, myocardial Ⅲ myocardium Ⅲ calcium Ⅲ reperfusion I ntracellular Ca 2ϩ overload on reperfusion after prolonged ischemia is an important pathophysiological factor that contributes to reduced postischemic recovery of mechanical function. 1, 2 It has been demonstrated that the Na ϩ /Ca 2ϩ exchanger is largely responsible for the excessive Ca 2ϩ influx during ischemia and reperfusion, which occurs secondary to intracellular Na ϩ overload. [3] [4] [5] It has been hypothesized that during early reperfusion, Ca 2ϩ overload is aggravated by the activation of the Na ϩ /H ϩ exchanger, with protons extruded in exchange for Na ϩ on realkalinization. Pretreatment with Na ϩ /H ϩ exchange has been shown to provide substantial improvement of postischemic recovery in vivo and in isolated muscle preparations: amiloride, the classic Na ϩ /H ϩ exchange inhibitor, improved postischemic recovery and attenuated intracellular Ca 2ϩ overload. [5] [6] [7] However, its effect on Na ϩ /H ϩ exchange is rather nonspecific, because it also inhibits Na ϩ /Ca 2ϩ exchange, 6 the T-type Ca 2ϩ -and the tetrodotoxin-sensitive Na ϩ channels. 8 The first specific Na ϩ /H ϩ exchange inhibitor, HOE694, demonstrated cardioprotective effects in ischemiareperfusion injury. 8, 9 Efforts to further improve potency and specificity led to the development of HOE642 (cariporide), a selective Na ϩ /H ϩ exchanger subtype I (the prevailing cardiovascular subtype) inhibitor. In a variety of ischemia models, HOE642 revealed a similar cardioprotective effect. 10 The preliminary results of a large multicenter trial (Guardian Trial) revealed beneficial effects of the drug in patients with acute coronary syndromes. 11 However, results of studies on the precise mechanisms of action of HOE642 in ischemia-reperfusion have not been reported. It has been hypothesized that the cardioprotective effect of Na ϩ /H ϩ exchange inhibition is mediated by delayed realkalinization on reperfusion with consequent attenuation of Na ϩ overload and, thus, intracellular Ca 2ϩ overload. 4 Both preservation of acidosis and reduced Ca 2ϩ overload were shown to be cardioprotective. 3, 12 To test this hypothesis for HOE642 during ischemia-reperfusion, measurements of intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) and pH i with high temporal resolution are required. In the present study, we used aequorin bioluminescence and 31 P NMR spectroscopy techniques to assess [Ca 2ϩ ] i and pH i , respectively, in an isolated heart model.
Methods

Isolated Heart
Studies were conducted according to the guidelines of the American Physiological Society Principles for Research Involving Animals and Human Beings. Isolated hearts were dissected and perfused as described previously. 13 Briefly, male Wistar rats aged 8 to 10 weeks with a body weight of 300 to 330 g and a heart weight of 1.2 to 1.3 g were anesthetized with intraperitoneal pentobarbital, and the hearts were retrogradely perfused within 30 seconds after thoracotomy with an oxygenated (95% O 2 /5% CO 2 , pH 7.4, at 37°C) Krebs-Henseleit solution containing (in mmol/L) NaCl 118, KCl 4.7, NaHCO 3 23, MgCl 2 1.2, CaCl 2 1.5, and dextrose 5.2. Left ventricular (LV) isovolumic pressure was recorded with an intraventricular latex balloon attached to a Statham P 23 XL transducer. The hearts were paced at 5 Hz with rectangular wave pulses (5 ms, 5 to 10 V, 20% above threshold). Cardiac temperature was monitored with a temperature probe inserted into the right ventricle. Care was taken to ensure isothermic conditions (37.0Ϯ0.3°C) during the ischemia protocol with a temperature-regulated organ bath (Gary Harrer). Coronary flow was set at 12 mL ⅐ min Ϫ1 ⅐ g heart wt Ϫ1 , yielding a coronary perfusion pressure of 60 to 70 mm Hg. This flow rate was kept constant except during no-flow ischemia.
LV Pressure Recordings
LV pressure tracings were digitized with a 12-bit AD converter (sampling rate 1 kHz) and stored on magnetic disk. LV developed and end-diastolic pressures (LVDP and LVEDP, respectively), time to peak contraction (TP), time constant of exponential pressure decay (tau; with use of the variable asymptote method 14 ) , and maximum and minimum values of the first derivative of pressure normalized by LVDP (ϩdP/dt/LVDP and ϪdP/dt/LVDP, respectively) were derived from the pressure tracing.
Aequorin Loading and Normalization of Light Signals
Aequorin was macroinjected, and the heart was positioned in an organ bath as described previously. 15 Aequorin light signals were measured with a photomultiplier 15 and digitized and stored as described for LV pressure. The light signals were analyzed for peak systolic (L sys ) and end-diastolic (L dias ) light. To reduce the signal-tonoise ratio, 10 to 100 cycles were wave averaged at the time of interest when function was stable (Ͻ5% difference of LVDP) and pacing was possible. Because the magnitude of the aequorin light signal depends on the amount of aequorin that had entered the cell during the loading procedure, the light signal must be normalized according to the following technique: HOE642 does not alter intracellular Ca 2ϩ transients under normoxic conditions (see Results). Therefore, the preischemic amplitude of the Ca 2ϩ light transients (⌬L) was chosen as a normalization reference. Because aequorin is consumed throughout the experiment, light values cannot simply be related to preischemic values as 100%, and aequorin consumption must be taken into account. For the conversion of light to calcium concentration, the method of fractional luminescence is used as described previously 15 : ] i at any other time point of the respective experiment with the use of equations 1, 2, and 3.
Analysis of Calcium Overload in the First Minute of Reperfusion
To analyze Ca 2ϩ overload occurring in the first minute of reperfusion, the following parameters were used (Figure 2 , bottom). [Ca 2ϩ ] isch was end-ischemic [Ca 2ϩ ] i ; peak was the initial peak of Ca 2ϩ signal in the first minute of reperfusion, reflecting the first Ca 2ϩ influx; Oscill max was the maximum of the first 10 transients of Ca 2ϩ oscillations in the first minute of reperfusion, reflecting the amount of Ca 2ϩ released from the overloaded sarcoplasmic reticulum during each oscillation on top of the cytosolic Ca 2ϩ overload; I (0 -30) and I (30 -60) were the time integrals of the first or second 30 seconds of reperfusion, respectively, normalized by L max (t), a global Ca 2ϩ overload index; and I (0 -30) /I (30 -60) was the index of Ca 2ϩ overload distribution with respect to time. The time intervals for I (0 -30) and I (30 -60) were chosen according to preliminary experiments, demonstrating that the major part of the peak of the reperfusion-induced Ca 2ϩ overload is over within 1 minute and that no significant differences could be detected for light integral measurements of Ն1 minute.
Measurement of pH i With 31 P NMR Spectroscopy
For NMR measurements, hearts were perfused in an NMR sample tube and inserted into the bore of a Bruker (AM 300) 7.05-T magnet (150 mm; Oxford Instruments) as previously described. 16 31 P NMR spectra were collected at 121.5 MHz during 30-second intervals by signal-averaging 16 free induction decays with a pulse angle of 45°( recycle time 1.93 seconds). The free induction decays were analyzed in time domain (AMARES fit routine), 17 and the inorganic phosphate (Pi) and phosphocreatine (PCr) resonance areas were analyzed (MRUI package). The chemical shift difference between Pi and PCr was used to obtain pH values from a standard curve. 18 
Experimental Protocol (Aequorin Experiments)
After the aequorin loading procedure, the temperature was increased to 37°C within 10 minutes, and the hearts were paced at 5 Hz. After steady state conditions were reached, a pressure-volume relationship was obtained to determine the volume at peak developed pressure (Vol max ) as previously described. 13 LV volume was set to 50% of Vol max and kept constant for the remainder of the experiment. After stabilization of mechanical function and aequorin light signals, HOE642 was added into the perfusate in the treated group, resulting in a concentration of 1 mol/L. Vehicle (0.9% NaCl solution) was added to the perfusate in the untreated group (nϭ10 per group). Fifteen minutes later, no-flow ischemia was initiated. Pacing was discontinued 5 minutes after the initiation of ischemia. Hearts were reperfused after 30 minutes of ischemia. In all hearts, transient ventricular fibrillation occurred. Pacing was reinitiated after stabilization of the cardiac rhythm Ϸ5 minutes after spontaneous defibrillation. The hearts were reperfused for 30 minutes after spontaneous defibrillation.
Experimental Protocol (NMR Experiments)
Additional groups of hearts were examined (6 untreated, 6 HOE642 treated) with the NMR spectrometer as described earlier to measure pH i . No aequorin loading was performed in these hearts, but otherwise, hearts were subjected to the same protocol.
Statistical Analysis
Data are reported as meanϮSEM. A paired t test or a repeated measures ANOVA for within-group comparisons was performed where appropriate. A value of PϽ0.05 indicates significant differences between treated and untreated groups.
Results
Effects of HOE642 on Baseline Cardiac Performance
No significant changes in mechanical function, [Ca 2ϩ ] i , or pH i were induced with HOE642 under preischemic (values not shown) conditions, and all preischemic parameters for untreated and HOE642 hearts were similar ( Figures 1A to 1F , Table) .
Cardiac Function During Ischemia and Reperfusion
After the beginning of no-flow ischemia, LVDP declined to zero within Ͻ5 minutes ( Figures 1A and 2) . Ischemic contracture developed after Ϸ5 minutes up to 32 mm Hg ( Figures 1B and 2 ). In the second half of the ischemic period, resting pressure declined slightly to 24 mm Hg at the end of the ischemic period ( Figure 1B ). No differences in mechanical function or resting pressure, respectively, could be detected up to this time point between HOE642-treated and untreated hearts. On reperfusion, LVEDP increased to 60Ϯ4.3 mm Hg in untreated hearts compared with 47Ϯ2.8 mm Hg in the treated hearts (PϽ0.05). All hearts showed low-amplitude contractions before going into ventricular fibrillation within 2 minutes (Figure 2) . Time of ventricular fibrillation was not abbreviated with HOE642 treatment. After an average of 9Ϯ2 minutes, hearts spontaneously defibrillated. In the next 20 minutes of reperfusion, LVEDP slowly declined and LVDP increased, reaching a stable plateau 20 to 30 minutes after spontaneous defibrillation, resulting in an LVDP of 49.6Ϯ7.7 in untreated and 92.5Ϯ3.2 (values are percent of preischemic values) in treated hearts, respectively (PϽ0.05; Figure 1A) . Similarly, at the end of reperfusion, LVEDP was 43Ϯ6.8 mm Hg in untreated hearts compared with 15Ϯ3.1 mm Hg in the HOE642 group (PϽ0.05; Figure 1B ). Coronary perfusion pressure was not influenced by HOE642 treatment throughout the protocol ( Figure 1C ).
After reperfusion, TP was prolonged and ϩdP/dt/LVDP was decreased compared with preischemic values. Relaxation was impaired after reperfusion as indicated by an increase of tau and decrease in ϪdP/dt/LVDP. These abnormalities could be completely prevented with HOE642 treatment (Table) .
The reported LV pressure results were taken from aequorin experiments. Measurements in NMR experiments showed similar results.
Intracellular Ca 2؉ During Ischemia and Reperfusion
In the first few minutes of ischemia, the amplitude of the Ca 2ϩ transient increased by Ϸ30% in both groups and fell to zero after pacing was terminated ( Figures 1E and 2 ). During ischemia, intracellular resting Ca 2ϩ increased, as indicated by an increase in the aequorin light signal normalized by L max(t) ( Figures 1F and 2 ). HOE642 treatment significantly blunted the ischemic Ca 2ϩ overload. On reperfusion, intracellular Ca 2ϩ markedly increased, reaching its peak after 15 to 20 seconds, in parallel to an increase in LV resting pressure (Figure 2, bottom) (Figure 2 ) with no differences between the groups after the first minute.
Peak systolic and LV end-diastolic [Ca 2ϩ ] i in untreated and HOE642-treated hearts were similar in both groups 30 minutes after reperfusion. There were no differences from preischemic values ( Figure 1E ), suggesting that the availability of Ca 2ϩ to activate the myofilaments was not responsible for postischemic dysfunction.
pH i on Reperfusion
Preischemic pH i was similar for both groups. During ischemia, pH i declined at a similar rate and extent, by 1.2 pH units, in both groups ( Figure 1D ). On reperfusion, pH i was rapidly restored in the untreated group within 2 minutes ( Figures 1D and 4) . In the HOE642-treated group, recovery of pH i was similar for the first 90 seconds of reperfusion. However, for the next 3 minutes of reperfusion, realkalinization was significantly delayed in HOE642-treated compared with untreated hearts. Later, pH i reached preischemic values in both groups.
Discussion
In the present study, we investigated the cardioprotective effects of HOE642, a cardioselective Na ϩ /H ϩ exchange inhibitor, during ischemia-reperfusion injury. To our knowledge, this is the first report on [Ca 2ϩ ] i and pH i measurements of the effects of a Na ϩ /H ϩ exchange inhibitor with a temporal resolution of Յ30 seconds, the resolution required to evaluate fast changes of proton and Ca 2ϩ homeostasis on reperfusion. 
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During ischemia, acidosis develops due to ATP breakdown and lactate production. 3, 19 The low pH i stimulates pH regulating transport systems such as the Na ϩ /H ϩ exchanger. After no-flow ischemia, extracellular pH drops secondary to intracellular acidification, thus likely reducing the activity of the Na ϩ /H ϩ exchanger. 3 On reperfusion, extracellular pH is immediately restored with a rapid increase in extracellular pH, and the Na ϩ /H ϩ exchanger is reactivated. 20 The Na ϩ /H ϩ exchanger then contributes to transient Na ϩ overload linked to Ca 2ϩ overload via the Na ϩ /Ca 2ϩ exchanger working in reverse mode (Na ϩ out, Ca 2ϩ in). 20 Events during the first few minutes of reperfusion are considered to be the main determinants of reperfusion injury. 12 One of the major factors for reperfusion injury leading to stunning, necrosis, and arrhythmias is the Ca 2ϩ overload phenomenon. 2 Intracellular acidosis during the early phase of reperfusion can protect the myofilaments against reperfusion injury. 
Ca
2؉ Overload and pH i on Reperfusion
In the present study, the Ca 2ϩ overload phenomenon was characterized in an isolated heart model with a temporal resolution of a few milliseconds. This resolution was sufficient to detect not only a global increase in [Ca 2ϩ ] i on reperfusion, as found with NMR indicator techniques 5, 7 or radioactive calcium, 21 To analyze the effects of HOE642 on reperfusion-induced Ca 2ϩ overload, various indices were defined as described in Methods and in Figure 2 . In the present report, all Ca 2ϩ overload indices were depressed with HOE642 treatment, although differences for Oscill max were not significant ( Figure  3) . Furthermore, Ca 2ϩ overload on reperfusion was delayed by HOE642, as indicated by a reduced I (0 -30) /I (30 -60) ratio. Although the reduction in Ca 2ϩ overload with HOE642 was evident only during the first minute of reperfusion, [Ca 2ϩ ] i was still elevated for the next 4 minutes. The rise in pH i makes the myofilaments most sensitive to injury after the first minute of reperfusion. Realkalinization was delayed from the second to the fourth minute of reperfusion by HOE642 ( Figures 1D and 4) . Therefore, both the effects on [Ca 2ϩ ] i and on pH i are cardioprotective and may explain the markedly beneficial effect on postischemic recovery of systolic and diastolic functions ( Figures 1A, 1B, and 2 , Table) . 3, 12 In cardiomyocytes, the Na ϩ /H ϩ exchanger is only 1 of several pH-regulating systems 3 : protons can leave the cell via the lactate/H ϩ symporter if lactate is present and via the Na ϩ /HCO 3 Ϫ symporter depending on the Na ϩ gradient across the cell membrane. 3 The relative importance of these mechanisms is unknown. In the concentration used for the present study, HOE642 (1 mol/L) inhibits Ͼ95% of Na ϩ /H ϩ exchanger subtype I, the predominant subtype in cardiac tissue. 4, 10 Na ϩ /H ϩ exchange is immediately activated on reperfusion by a reestablished pH gradient. Therefore, its inhibition can explain the observed reduction in Ca 2ϩ influx (Figure 3) . Because pH i was found to be similar in both groups during the first 90 seconds of reperfusion (Figure 4) , the expected effect of HOE642 on pH i during this period was overridden by alternative mechanisms other than Na ϩ /H ϩ exchange, presumably by lactate/H ϩ washout. Subsequently, inhibition of Na ϩ /H ϩ exchange predominates as indicated by the differences in pH i 2 to 5 minutes after reperfusion (Figure 4) .
The observation that Na ϩ /H ϩ exchange inhibition improves postischemic mechanical function is consistent with results from other groups who used in vivo or in vitro models of cardiac ischemia in various species. 6, 10, 23 A decrease in Na ϩ and Ca 2ϩ overload was demonstrated during 20 minutes of ischemia with NMR spectroscopy 7 or 45 Ca 2ϩ using the nonspecific Na ϩ /H ϩ exchange inhibitor amiloride in isolated hearts. 5 Pretreatment with HOE694, a selective, but less potent, Na ϩ /H ϩ exchange inhibitor compared with HOE642, improved cardiac output in the isolated working heart after 20 minutes of global ischemia. 9 In blood-perfused isolated rabbit hearts subjected to 45 minutes of ischemia and 60 minutes of reperfusion, HOE694 improved postischemic recovery of systolic and diastolic function. High-energy phosphates and pH i measured with 31 P NMR spectroscopy were similar during ischemia. ATP and PCr depletion were attenuated by HOE694 after 60 minutes of reperfusion. pH i showed a transient overalkalinization in untreated hearts 5 minutes after the beginning of reperfusion (time resolution 5 minutes), an effect abolished with HOE694. 8 In contrast to our findings, ischemic contracture was reported to be attenuated by a Na ϩ /H ϩ exchange inhibitor, and the incidence of reperfusion-induced arrhythmias was reduced. 9, 10, 24 However, either these experiments were performed with regional ischemia in vivo or in vitro, or the duration of global no-flow ischemia was markedly shorter than that in our experiments. It is conceivable that the effects of Na ϩ /H ϩ exchange inhibition on ischemic contracture or reperfusion-induced arrhythmias exist for only a lesser degree of ischemic damage. In accordance with the present report, selective inhibition of Na ϩ /H ϩ exchange did not attenuate ischemic contracture during Ն40 minutes of no-flow ischemia in isolated buffer-perfused rat hearts 25 or in bloodperfused rabbit hearts. 8 Although there were significant differences for [Ca 2ϩ ] i during ischemia, ischemic contracture was virtually identical in both groups ( Figures 1B and 1F ). This observation is in accordance with the view that during ischemia, the myofilaments are desensitized by acidosis and accumulation of Pi. 26 Ischemic contracture is presumably caused solely by rigor bond formation after a decrease in free energy (⌬G). 26 However, in contrast to Ca 2ϩ overload, ischemic energy metabolism was found to be unaltered by Na ϩ /H ϩ exchange inhibition. 8 The reduced accumulation of [Ca 2ϩ ] i during ischemia is likely to render the myocytes less prone to further Ca 2ϩ overload on reperfusion. This finding is consistent with previous reports that provide evidence that Na ϩ /H ϩ exchange inhibitors are more effective when given before ischemia rather than at the time of reperfusion. 27, 28 
Study Limitations
The changes in pH i and [Ca 2ϩ ] i are independent observations, possibly but not necessarily related. According to current consensus, 3, 4, 8 improved susceptibility to ischemia is most likely linked to the observed changes in pH i and [Ca 2ϩ ] i , but no direct proof for this interrelation was given by the present data.
The aequorin light signal depends not only on [Ca 2ϩ ] i but also on pH i , in the sense that both ions compete for Ca 2ϩ -binding sites of the aequorin molecule. 29 However, because pH i was comparable in both groups during ischemia and during the first minute of reperfusion, [Ca 2ϩ ] i values quantified with the use of fractional luminescence were underestimated, but the relative differences between the treated and untreated hearts were unaffected.
Clinical Potential
In view of the experimental data, it is conceivable that HOE642 may become a clinically useful form of treatment in situations in which ischemia and reperfusion occur, such as cardioplegia during cardiac surgery, acute coronary syndrome, or before acute revascularization with angioplasty, bypass surgery, or thrombolysis. Patients with diagnosed coronary artery disease who are at risk for further ischemic events might be candidates for long-term treatment with HOE642. The preliminary results of a first clinical trial (Guardian Trial), revealing the beneficial effects of HOE642 in patients undergoing high-risk revascularization and preventing Q wave infarcts in patients with acute coronary syndrome, were promising. 11 
